Marshall Wace
VERA icon

Marshall Wace’s Vera Therapeutics VERA Stock Holding History

Marshall Wace’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,872
Closed -$398K – 3443
2025
Q2 		$398K Sell
16,872
-172,375
-91% -$3.88M ﹤0.01% 2220
2025
Q1 		$4.55M Sell
189,247
-647,899
-77% -$20.8M 0.01% 1111
2024
Q4 		$35.4M Buy
837,146
+253,421
+43% +$11.2M 0.04% 369
2024
Q3 		$25.8M Buy
583,725
+59,147
+11% +$2.24M 0.03% 434
2024
Q2 		$19M Buy
524,578
+44,059
+9% +$1.75M 0.03% 523
2024
Q1 		$20.7M Buy
+480,519
New +$17.1M 0.03% 500
2023
Q3 		– Sell
-14,699
Closed -$236K – 2723
2023
Q2 		$236K Sell
14,699
-30,087
-67% -$272K ﹤0.01% 2204
2023
Q1 		$348K Buy
+44,786
New +$346K ﹤0.01% 2244

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace's VERA Position: Q3 2025 in Review

Marshall Wace sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 16,872 shares — an estimated $398K sold.

Marshall Wace first reported a position in VERA in Q1 2023 and held it in 8 quarters. The position peaked at $35.4M in Q4 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Marshall Wace reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 16,872 Vera Therapeutics shares in Q3 2025, an estimated $398K.
  • Marshall Wace first reported a position in Vera Therapeutics in Q1 2023 and held it in 8 quarters.
  • Marshall Wace's Vera Therapeutics position peaked at $35.4M in Q4 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.